Craniospinal irradiation is employed in the treatment of:
**Core Concept**
Craniospinal irradiation is a form of radiation therapy used to treat primary central nervous system (CNS) tumors that have a high risk of spreading to the spinal cord. This treatment modality involves delivering radiation to the entire brain and spinal cord to prevent the dissemination of cancer cells.
**Why the Correct Answer is Right**
Medulloblastoma is a highly malignant, primitive neuroectodermal tumor (PNET) that originates in the cerebellum and has a high propensity for spreading to the spinal cord via the cerebrospinal fluid (CSF). As a result, craniospinal irradiation is employed as part of the treatment protocol to prevent or treat leptomeningeal seeding, which is a common mode of spread for medulloblastoma. This approach helps to eradicate any microscopic disease that may have already disseminated to the spinal cord.
**Why Each Wrong Option is Incorrect**
**Option A:** Oligodendroglioma is a type of glioma that typically responds well to surgery and chemotherapy, with radiation therapy being used more selectively for residual or recurrent disease. Craniospinal irradiation is not a standard treatment approach for oligodendroglioma.
**Option B:** Pilocytic astrocytoma is a low-grade glioma that usually has a favorable prognosis, with surgical resection often being the primary treatment modality. Craniospinal irradiation is not typically employed in the treatment of pilocytic astrocytoma.
**Option C:** Mixed oligoastrocytoma is a type of glioma that combines features of oligodendroglioma and astrocytoma. While radiation therapy may be used in the treatment of mixed oligoastrocytoma, craniospinal irradiation is not a standard approach for this tumor type.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that craniospinal irradiation is primarily used for tumors with a high risk of leptomeningeal seeding, such as medulloblastoma and other PNETs. This treatment modality should be distinguished from whole-brain radiation, which is used to treat tumors with a high risk of brain metastases.
**β Correct Answer: D. Medulloblastoma**